Related Experiment Video
Updated: Oct 27, 2025

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer
Santosh Lamichhane1, Ji-Su Mo2, Grinsun Sharma1
1Department of Pathology, School of Medicine, Wonkwang University, Iksan, Chonbuk, 54538, Republic of Korea.
Objective:
MicroRNAs are a class of small, non-coding RNAs that play a key role in several biological and molecular processes, including tumorigenesis. We previously identified that MIR452 is upregulated in both colorectal cancer (CRC) and colitis. However, the functional mechanisms of MIR452 and its target genes in CRC and colitis are not well understood. So, we hypothesize that MIR452 can influence CRC and DSS-induced colitis model through the regulation of IL20RA and its downstream JAK-STATs signaling pathway.
Methods:
We used a luciferase reporter assay to confirm the effect of MIR452 on IL20RA expression. The protein and mRNA expression of a target gene and its associated molecules were measured by western blot, quantitative RT-PCR, and immunohistochemistry.
Results:
We found that the IL20RA was a direct target gene of MIR452. Overexpression of MIR452 in CRC cell lines significantly decreased IL20RA and its downstream Janus kinase 1 (JAK1), Signal transducer and activator of transcription 1 (STAT1) and STAT3. Knockdown of IL20RA in CRC cell lines by IL20RA gene silencing also decreased the expression of IL20RA, JAK1, and STAT3, but not of STAT1.
Conclusion:
Our results suggest that MIR452 regulates STAT3 through the IL20RA-mediated JAK1 pathway, but not STAT1. Overall, MIR452 acts as tumor suppressor in human CRC and in a mouse colitis model. These findings suggest that MIR452 is a promising therapeutic target in the treatment of cancer and colitis.
Insights
MicroRNA 452 (MIR452) suppresses colorectal cancer (CRC) and colitis by targeting IL20RA, regulating the JAK1-STAT3 pathway. This suggests MIR452 as a potential therapeutic target for these conditions.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- MicroRNAs (miRNAs) are key regulators in biological processes, including cancer development.
- MIR452 is upregulated in colorectal cancer (CRC) and colitis, but its functional role remains unclear.
- Understanding MIR452's targets and pathways is crucial for CRC and colitis research.
Purpose of the Study:
- To investigate the functional mechanisms of MIR452 in colorectal cancer and a DSS-induced colitis model.
- To determine if MIR452 regulates IL20RA and its downstream JAK-STAT signaling pathway.
- To elucidate the role of MIR452 as a potential therapeutic target.
Main Methods:
- Luciferase reporter assays to confirm MIR452 targeting of IL20RA.
- Western blot and quantitative RT-PCR to measure gene and protein expression.
- Immunohistochemistry to assess molecular changes in CRC and colitis models.
Main Results:
- IL20RA was identified as a direct target gene of MIR452.
- MIR452 overexpression decreased IL20RA, JAK1, and STAT3 expression in CRC cells.
- IL20RA knockdown reduced IL20RA, JAK1, and STAT3, but not STAT1 expression.
Conclusions:
- MIR452 regulates STAT3 via the IL20RA-mediated JAK1 pathway, independent of STAT1.
- MIR452 functions as a tumor suppressor in human CRC and a mouse colitis model.
- MIR452 presents a promising therapeutic target for cancer and colitis treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

